SCHEMBL1444871

SCHEMBL1444871

C#CCCCC(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL17749604 0.98 TSHR (0.58)
SCHEMBL5153957 0.93 TSHR (0.58)
SCHEMBL6037361 0.92 TSHR (0.67)
SCHEMBL15541706 0.91 MAPT (0.57)
SCHEMBL1246192 0.91 MAPT (0.57)
SCHEMBL17981462 0.91 MAPT (0.57)
SCHEMBL3260470 0.91 MAPT (0.57)
SCHEMBL2467407 0.91 MAPT (0.57)
SCHEMBL22836423 0.91 MAPT (0.57)
SCHEMBL1049466 0.91 MAPT (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4667495-A2 BIOACTIVE MOLECULE CONJUGATE, PREPARATION METHOD AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2025-12-24 EP claimed
WO-2025045973-A1 SYNTHESIS OF LANIFIBRANOR INTERMEDIATE INVENTIVA (FR) 2025-03-06 WO claimed
CN-119306732-A Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2025-01-14 CN claimed
CN-119219654-A Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-12-31 CN claimed
CN-118496190-A Preparation method of 13-methyl- (5Z, 8Z) -tridecyldienolide 宜宾五粮液股份有限公司 2024-08-16 CN claimed
US-20230357259-A1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2023-11-09 US claimed
CN-116375749-A Trans-alkenyl potassium trifluoroborate and synthesis method thereof 西安近代化学研究所 2023-07-04 CN claimed
CN-121986098-A Synthesis of lanuno intermediates 伊文蒂瓦公司 2026-05-05 CN disclosed
US-12617749-B2 Cannabinoid derivatives and precursors, and asymmetric synthesis for same KARE CHEMICAL TECHNOLOGIES INC. (CA) 2026-05-05 US disclosed
US-12576156-B2 Compound comprising self-immolative group and ligand-drug conjugate comprising same TRIOAR, INC. (KR) 2026-03-17 US disclosed
EP-3725798-B1 BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD (CN) 2026-03-04 EP disclosed
EP-4673475-A1 ANTIBODY-DRUG CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF MULTITUDE THERAPEUTICS INC. (CN) 2026-01-07 EP disclosed
EP-4667495-A2 BIOACTIVE MOLECULE CONJUGATE, PREPARATION METHOD AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2025-12-24 EP disclosed
WO-1993023420-A1 NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS MERCK & CO., INC. (US) 1993-11-25 WO disclosed
CN-1071423-A BICYCLIC CARBOXYLIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 1993-04-28 CN disclosed
EP-0531823-A1 Bicyclic carboxylic acid derivatives as anti-inflammatory agents F. HOFFMANN-LA ROCHE AG (CH) 1993-03-17 EP disclosed
US-5149859-A Cardiovascular disorders TEIJIN LIMITED (JP) 1992-09-22 US disclosed
EP-0418038-A1 Naphthalene derivative and preparation method thereof TEIJIN LIMITED (JP) 1991-03-20 EP disclosed
US-4867915-A LIPOXYGENASE INHIBITORS, ANTIINFLAMMATORY AGENTS SYNTEX (U.S.A.) INC. (US) 1989-09-19 US disclosed
US-4405810-A ANTIALLERGENS, BRONCHODILATORS SCHERING CORPORATION (US) 1983-09-20 US disclosed